Maria Vilenchik
8Patents
2h-index
17Co-inventors
48Inventor score
Filing activity: Dec 16, 1992 → Jun 17, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10322128B2 | Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors | Human Necessities | 2 | Active |
| US5643717A | Substrate useful for separating modified oligonucleotides | Physics | 2 | Expired |
| US5637464A | Method of detecting sub-ppb levels of oligonucleotides in biological fluids | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5420265A | Separation of phosphorothioate oligonucleotides by capillary gel electrophoresis | Physics | 1 | Expired |
| US5627277A | Method for analyzing oligonucleotide analogs | Physics | 1 | Expired |
| US10314843B2 | Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis | Human Necessities | 1 | Active |
| US10577365B2 | Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases | Chemistry; Metallurgy | 0 | Active |
| US11202779B2 | Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.